| COVID-19 |
1 |
1 |
| Child |
0 |
0.99 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.98 |
| Nausea |
0 |
0.35 |
| Otolaryngology |
0 |
0.34 |
| Arrhythmia |
0 |
0.32 |
| Pain Management |
0 |
0.3 |
| Brain |
0 |
0.25 |
| Heart |
0 |
0.25 |
| Care and Maintenance of Vision |
0 |
0.21 |
| Dizziness |
0 |
0.2 |
| Depression |
0 |
0.17 |
| Headache |
0 |
0.17 |
| Fatigue |
0 |
0.15 |
| Cataract |
0 |
0.12 |
| A-Scan Biometry |
0 |
0.1 |
| Blood |
0 |
0.1 |
| Scan |
0 |
0.1 |
| Anxiety Disorder |
0 |
0.06 |
| Retinal Diseases |
0 |
0.06 |
| Weight Management |
0 |
0.06 |
| Adolescent Medicine |
0 |
0.05 |
| Anxiety |
0 |
0.05 |
| Aura |
0 |
0.05 |
| Beta-Adrenergic Agonist |
0 |
0.05 |
| Blind Spot |
0 |
0.05 |
| Caregiver |
0 |
0.05 |
| Cough |
0 |
0.05 |
| Diet |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Fellowship |
0 |
0.05 |
| Fever |
0 |
0.05 |
| Field of Vision |
0 |
0.05 |
| Hair |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Magnetic Resonance Imaging |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Spain |
0 |
0.05 |
| Statistics |
0 |
0.05 |
| Tachycardia |
0 |
0.05 |
| Weight Gain |
0 |
0.05 |